181 related articles for article (PubMed ID: 35096360)
1. Primary central nervous system lymphoma in the United States, 1975-2017.
Lv C; Wang J; Zhou M; Xu JY; Chen B; Wan Y
Ther Adv Hematol; 2022; 13():20406207211066166. PubMed ID: 35096360
[TBL] [Abstract][Full Text] [Related]
2. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
Mendez JS; Ostrom QT; Gittleman H; Kruchko C; DeAngelis LM; Barnholtz-Sloan JS; Grommes C
Neuro Oncol; 2018 Apr; 20(5):687-694. PubMed ID: 29036697
[TBL] [Abstract][Full Text] [Related]
3. Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Shiels MS; Pfeiffer RM; Besson C; Clarke CA; Morton LM; Nogueira L; Pawlish K; Yanik EL; Suneja G; Engels EA
Br J Haematol; 2016 Aug; 174(3):417-24. PubMed ID: 27018254
[TBL] [Abstract][Full Text] [Related]
4. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.
O'Neill BP; Decker PA; Tieu C; Cerhan JR
Am J Hematol; 2013 Dec; 88(12):997-1000. PubMed ID: 23873804
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
6. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
[TBL] [Abstract][Full Text] [Related]
7. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
8. Primary treatment and recent survival trends in patients with primary diffuse large B-cell lymphoma of central nervous system, 1995-2016: A population-based SEER analysis.
Chen C; Sun P; Sun XQ; Chen SY; Hang Yang ; Wang Y; Li ZM
Hematol Oncol; 2023 Apr; 41(2):248-256. PubMed ID: 34472655
[TBL] [Abstract][Full Text] [Related]
9. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
10. Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study.
Farrall AL; Smith JR
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499081
[TBL] [Abstract][Full Text] [Related]
11. Conditional survival of elderly primary central nervous system lymphoma.
Qian H; Yang Z; Cai L; Chen H
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13391-13401. PubMed ID: 37491638
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis.
Puhakka I; Kuitunen H; Jäkälä P; Sonkajärvi E; Turpeenniemi-Hujanen T; Rönkä A; Selander T; Korhonen M; Kuittinen O
BMC Cancer; 2022 Mar; 22(1):236. PubMed ID: 35241020
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
15. All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis.
Furst T; Hoffman H; Chin LS
J Neurosurg Sci; 2024 Feb; 68(1):44-50. PubMed ID: 31601065
[TBL] [Abstract][Full Text] [Related]
16. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
17. Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study.
Chi K; Zhou R; Luo Z; Zhao H; Jiang Y; He B; Li Y; Chen D; Feng M; Liang Y; Yang W; Liu R; Yao D; Lin X; Xu X
Front Oncol; 2023; 13():1096027. PubMed ID: 36845683
[TBL] [Abstract][Full Text] [Related]
18. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
19. Primary Breast Lymphoma in the United States: 1975-2013.
Thomas A; Link BK; Altekruse S; Romitti PA; Schroeder MC
J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28376147
[TBL] [Abstract][Full Text] [Related]
20. Decreasing incidence rates of primary central nervous system lymphoma.
Kadan-Lottick NS; Skluzacek MC; Gurney JG
Cancer; 2002 Jul; 95(1):193-202. PubMed ID: 12115333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]